Gotowa bibliografia na temat „Validation multicentrique”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Validation multicentrique”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Validation multicentrique"
Gravel, J., S. Manzano, C. Guimont, L. Lacroix, A. Gervaix i B. Bailey. "Validation multicentrique du score clinique de déshydratation pédiatrique". Archives de Pédiatrie 17, nr 12 (grudzień 2010): 1645–51. http://dx.doi.org/10.1016/j.arcped.2010.09.009.
Pełny tekst źródłaGodefroy, O. "Syndrome dysexécutif : validation de critères diagnostiques. Etude multicentrique GREFEX". Revue Neurologique 164 (styczeń 2008): 7–8. http://dx.doi.org/10.1016/s0035-3787(08)70030-4.
Pełny tekst źródłaRiachy, M., G. Juvelikian, G. Sleilaty, T. Bazarbachi, G. Khayat i C. Mouradides. "Validation de la version arabe de l’échelle de somnolence d’Epworth : étude multicentrique". Revue des Maladies Respiratoires 29, nr 5 (maj 2012): 697–704. http://dx.doi.org/10.1016/j.rmr.2011.12.017.
Pełny tekst źródłaRighetti-Veltema, Marion, Élisabeth Conne-PerréArd, Arnaud Bousquet i Juan Manzano. "Construction et validation multicentrique d'un questionnaire prépartum de dépistage de la dépression postpartum". La psychiatrie de l'enfant 49, nr 2 (2006): 513. http://dx.doi.org/10.3917/psye.492.0513.
Pełny tekst źródłaFaure, A., L. Fievet, N. Panait, H. Lehors, J. M. Guys, J. L. Jouve, P. Minodier i in. "SFCP CO-16 - Validation multicentrique et prospective du score de Samuel prédictif d’appendicite". Archives de Pédiatrie 21, nr 5 (maj 2014): 394. http://dx.doi.org/10.1016/s0929-693x(14)71654-9.
Pełny tekst źródłaLantuéjoul, S., I. Rouquette, H. Blons, N. Le Stang, M. Ilie, H. Begueret, V. Grégoire i in. "Validation multicentrique des outils diagnostiques des réarrangements du gène ALK dans 547 adénocarcinomes pulmonaires". Morphologie 99, nr 327 (grudzień 2015): 159–60. http://dx.doi.org/10.1016/j.morpho.2015.09.024.
Pełny tekst źródłaROUGER, P., D. GOOSSENS, J. LEBLANC i C. SALMON. "Etude multicentrique de validation d'un réactif anti-D produit à l'aide d'anticorps monoclonaux humains". Revue Francaise de Transfusion et Immuno-hématologie 28, nr 4 (wrzesień 1985): 293–99. http://dx.doi.org/10.1016/s0338-4535(85)80123-9.
Pełny tekst źródłaMouna, Aissi, Daouassi Nizar, Ben Mahmoud Imene, Boughammoura Amel i Frih Ayed Mahbouba. "Validation du score ABCD2 après un accident ischémique transitoire lors d’une étude multicentrique tunisienne". Revue Neurologique 171 (kwiecień 2015): A29. http://dx.doi.org/10.1016/j.neurol.2015.01.059.
Pełny tekst źródłaAl Tawil, Samah, Carla Irani, Riwa Kfoury, Soula Abramian, Pascale Salameh, Karsten Weller, Marcus Maurer i Khaled Ezzedine. "Évaluation de l’urticaire à l’aide d’un outil de diagnostic autodéclaré (SRUD) : une étude de validation multicentrique". Annales de Dermatologie et de Vénéréologie - FMC 1, nr 8 (grudzień 2021): A223. http://dx.doi.org/10.1016/j.fander.2021.09.173.
Pełny tekst źródłaLombardi, Y., L. Azoyan, P. Szychowiak, A. Bellamine, G. Lemaitre, M. Bernaux, C. Daniel, J. Leblanc, Q. Riller i O. Steichen. "Validation externe des scores pronostiques de la Covid-19 en hospitalisation : une étude de cohorte multicentrique". La Revue de Médecine Interne 42 (grudzień 2021): A331—A332. http://dx.doi.org/10.1016/j.revmed.2021.10.297.
Pełny tekst źródłaRozprawy doktorskie na temat "Validation multicentrique"
Nardi, Olivier. "Validation et intérêt thérapeutique de la mesure de la saturation musculaire en oxygène mesurée de manière non invasive au cours des syndromes septiques graves". Versailles-St Quentin en Yvelines, 2013. http://www.theses.fr/2013VERS0015.
Pełny tekst źródłaSeveral manufacturers have put on the healthcare market medical devices intended for evaluation and monitoring of microcirculation. The technical performance of the medical device has to be separated from clinical benefit which is impacted by the performance of the device but also by the downstream consequences of using the device as a diagnostic tool. Among the devices intended for microcirculation monitoring, the Inspectra spectrometer uses near infrared technology to noninvasively illuminate the tissue below and to evaluate local haemoglobin oxygen saturation (StO2). Our aim was to evaluate the added value of StO2 monitoring for the management of severe sepsis and septic shock. We present our results regarding feasibility of multi-site StO2 monitoring and the impact of adrenergic support on StO2 in a first study. We then described the relationship between StO2 and ScvO2 in three observational studies. Finally the therapeutic interest of StO2 optimisation was assessed in two clinical controlled trials, one pilot trial including 30 patients and one European multicentric trial including 103 patients
Jaouen, Tristan. "Caractérisation du cancer de la prostate de haut grade à l’IRM multiparamétrique à l’aide d’un système de diagnostic assisté par ordinateur basé sur la radiomique et utilisé comme lecteur autonome ou comme second lecteur". Electronic Thesis or Diss., Lyon, 2022. http://www.theses.fr/2022LYSE1140.
Pełny tekst źródłaWe developed a region of interest-based (ROIs) computer-aided diagnosis system (CAD) to characterize International Society of Urological Pathology grade (ISUP) ≥2 prostate cancers at multiparametric MRI (mp-MRI). Image parameters from two multi-vendor datasets of 265 pre-prostatectomy and 112 pre-biopsy MRIs were combined using logistic regression. The best models used the ADC 2nd percentile (ADC2) and normalized wash-in rate (WI) in the peripheral zone (PZ) and the ADC 25th percentile (ADC25) in the transition zone (TZ). They were combined in the CAD system. The CAD was retrospectively assessed on two multi-vendor datasets containing respectively 158 and 105 pre-biopsy MRIs from our institution (internal test dataset) and another institution (external test dataset). Two radiologists independently outlined lesions targeted at biopsy. The Prostate Imaging-Reporting and Data System version 2 (PI-RADSv2) score prospectively assigned at biopsy and the CAD score were compared to biopsy findings. At patient level, the areas under the Receiver Operating Characteristic curve (AUC) of the PI-RADSv2 score were 82% (95% CI: 74-87) and 85% (95% CI: 79-91) in the internal and external test datasets respectively. For both radiologists, the CAD score had similar AUC results in the internal (82%, 95% CI: 76-89, p=1; 84%, 95% CI: 78-91, p=1) and external (82%, 95% CI: 76-89, p=0.82; 86%, 95% CI: 79-93, p=1) test datasets. Combining PI-RADSv2 and CAD findings could have avoided 41-52% of biopsies while missing 6-10% of ISUP≥2 cancers. The CAD system confirmed its robustness showing good discrimination of ISUP ≥2 cancers in a multicentric study involving 22 different scanners with highly heterogeneous image protocols. In per patient analysis, the CAD and the PI-RADSv2 had similar AUC values (76%, 95% CI: 70-82 vs 79%, 95% CI: 73-86; p=0.34) and sensitivities (86%, 95% CI: 76-96 vs 89%, 95% CI: 79-98 for PI-RADSv2 ≥4). The specificity of the CAD (62%, 95% CI: 53-70 vs 49%, 95% CI: 39-59 for PI-RADSv2 ≥4) could be used to complement the PI-RADSv2 score and potentially avoid 50% of biopsies, while missing 13% of ISUP ≥2 cancers. These findings were very similar to those reported in the single center test cohorts. Given its robustness, the CAD could then be exploited in more specific applications. The CAD first provided good discrimination of ISUP ≥2 cancers in patients under Active Surveillance. Its AUC (80%, 95% CI: 74-86) was similar to that of the PI-RADS score prospectively assigned by specialized uro-radiologists at the time of biopsy (81%, 95% CI: 74-87; p=0.96). After dichotomization, the CAD was more specific than the PI-RADS ≥3 (p<0.001) and the PI-RADS ≥4 scores (p<0.001). It could offer a solution to select patients who could safely avoid confirmatory or follow-up biopsy during Active Surveillance (25%), while missing 5% of ISUP≥2 cancers. Finally, the CAD was tested with the pre-prostatectomy mp-MRIs of 56 Japanese patients, from a population which is geographically distant from its training population and which is of interest because of its low prostate cancer incidence and mortality. The CAD obtained an AUC similar to the PI-RADSv2 score assigned by an experience radiologist in the PZ (80%, 95% CI: 71-90 vs 80%, 95% CI: 71-89; p=0.886) and in the TZ (79%, 95% CI: 66-90 vs 93%, 95%CI: 82-96; p=0.051). These promising and robust results across heterogeneous datasets suggest that the CAD could be used in clinical routine as a second opinion reader to help select the patients who could safely avoid biopsy. This CAD may assist less experience readers in the characterization of prostate lesions